Announcements Trials
Browse Landscape

Phase

Phase 1 24Phase 1/2 17Phase 2 12Phase EARLY_PHASE1 3

Status

Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 12Plasma cell 8Other hematologic neoplasm 5Other solid neoplasm 4Gynecologic 3Head & Neck 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Ovarian Neoplasms 3Recurrence 1Neoplasms 1Neoplasm Metastasis 1

Interventions

olaparib 6Specimen Handling 5Paclitaxel 5Magnetic Resonance Spectroscopy 5Cyclophosphamide 4Carboplatin 4pembrolizumab 3fludarabine 3X-Rays 3Taxes 3Metformin 3Letrozole 3Fluorodeoxyglucose F18 3Biopsy 3Aspirin 3niraparib 2Tirzepatide 2Radiotherapy 2Propranolol 2Platinum 2Pafolacianine 2Oncolytic Virotherapy 2Hysterectomy 2Hyperthermic Intraperitoneal Chemotherapy 2Fluorescein 2Drug Therapy 2Doxorubicin 2Cytoreduction Surgical Procedures 2Cisplatin 21,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × fludarabine × Gynecologic × Clear all
NCT06825455 2025-02-13

Allogeneic B7H3 CAR-γδT Cell Therapy for Advanced Solid Tumors

Peking University

Phase EARLY_PHASE1 Not yet recruiting
18 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms

NCT03814447 2021-08-10

The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer

Shanghai 6th People's Hospital

Phase EARLY_PHASE1 Unknown
10 enrolled
Gynecologic

Ovarian Neoplasms

NCT03799913 2019-04-10

MESO-CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

Zhejiang University

Phase EARLY_PHASE1 Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡